Infectious Diseases Society of America (IDSA), 2019
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. It specifically discusses the care of children, pregnant and postpartum women, and nonpregnant adults and includes special considerations for patients who are severely immunocompromised, such as hematopoietic stem cell and solid organ transplant recipients.
It also adds new information on diagnostic testing, use of antivirals, and discusses when to use antibiotics and when to test for antiviral resistance, plus presents evidence on harm associated with routine use of corticosteroids.
The authors also include guidance on the use of rapid testing to diagnose influenza and discuss the value of point-of-care testing in community and hospital-based outpatient settings.
The guidelines can be accessed here.
&cópia de; 2022 Abbott. Todos os direitos reservados. Todas as marcas comerciais mencionadas são marcas comerciais do grupo de empresas Abbott ou de seus respectivos proprietários.
Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G Warnock, Mark Woodward, Johan Ärnlöv, CKD Prognosis Consortium
Estimated glomerular filtration rate and albumin-to-creatinine ratio testing for cardiovascular risk assessmentenAcesse agora
Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Avraham Karasik, Tiago Taveira-Gomes, Manuel Botana, Kåre I Birkeland, Marcus Thuresson, Levy Jäger, Manish M Sood, Gijs VanPottelbergh, Navdeep Tangri; on behalf of the CaReMe CKD Investigators
Prevalence, outcomes and cost of chronic kidney diseaseenAcesse agora